DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Gastric Cancer Market Analysis 2016 - Forecast to 2022" report to their offering.
This report analyzes the global markets for "Gastric Cancer". The market assessment is performed through standard and the tailored research methodology approach.
Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.
Key Topics Covered:
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Gastric Cancer Market by Testing Type
- Chest X-Ray
- Computed Tomography (CT or CAT) Scan
- Helicobacer Pylori
- Imaging Tests
- Magnetic Resonance Imaging (MRI) Scan
- Positron Emission Tomography (PET) Scan
- Upper Gastrointestinal (GI) Series
6 Gastric Cancer Market by Drug Class
- Doxorubicin Hydrochloride
- Mitomycin C
7 Gastric Cancer Market by Treatment Type
- Adjuvant chemotherapy
- Chemo Therapy
- Radiation therapy
- Targeted drugs therapy
8 Gastric Cancer Market by Geography
9 Vendor Landscaping
10 Company Profiles
10.1 Eli Lilly and Company
10.2 AstraZeneca Plc.
10.3 Biogen idec
10.4 Bristol Myers Squibb
10.5 F Hoffmann-La Roche
10.6 Genentech, Inc
10.8 Hoffmann-la Roche inc.
10.10 Merck KGaA
10.11 Novartis AG
10.13 Otsuka Pharmaceutical
10.14 Pacific edge diagnostics NZ
10.15 Roche Holdings AG
10.17 Zova biotherapeutics Inc.
For more information about this report visit http://www.researchandmarkets.com/research/mwjzz6/global_gastric